Daniel M. Klein - 01 Mar 2022 Form 4 Insider Report for Physicians Realty Trust

Role: SVP - Deputy CIO
Signature: Christopher M. Bartoli, as attorney-in-fact
Issuer symbol: N/A
Transactions as of: 01 Mar 2022
Net transactions value: -$85,713
Form type: 4
Filing time: 03 Mar 2022, 15:31:30 UTC
Previous filing: 23 Feb 2022
Next filing: 27 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DOC	Common shares, $0.01 par value	Award	$0	+12,242	+15%	$0.000000	96,143	01 Mar 2022	Direct	F1
transaction	DOC	Common shares, $0.01 par value	Tax liability	$85,713	-5,236	-5.4%	$16.37	90,907	01 Mar 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DOC	2022 Performance Based Restricted Share Unit Grant	Award	$0	+18,363		$0.000000	18,363	01 Mar 2022	Common shares, $0.01 par value	18,363		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted common shares granted under the Issuer's 2013 Equity Incentive Plan (the "Plan"), which will vest on March 1, 2023, subject to the terms of the grant.
F2	March 1, 2022 grant of performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. The exact number of shares to be issued upon vesting depends upon, among other things, the Issuer's financial performance. Subject to continued service, the shares, if any, will be issued following the performance period end date of December 31, 2024.

Content

Represents restricted common shares granted under the Issuer's 2013 Equity Incentive Plan (the "Plan"), which will vest on March 1, 2023, subject to the terms of the grant.

March 1, 2022 grant of performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. The exact number of shares to be issued upon vesting depends upon, among other things, the Issuer's financial performance. Subject to continued service, the shares, if any, will be issued following the performance period end date of December 31, 2024.